Neuroprotective Properties of a Standardized Extract from <i>Myracrodruon urundeuva</i> Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson’s Disease Model in Rats

<table>Immunohistochemistry for OX-42 (a marker for microglia), in the lesioned right striatum. A very high number of immunopositive cells are present in the untreated 6-OHDA group, as related to the 6-OHDA group after treatments with SEMU (20 and 40 mg/kg, p.o.). Almost no immunopositive cells were noticed in the SO group (magnification: 400x). Arrows indicate OX-42 immunopositive cells.</table>

Parkinson’s Disease

fig7

Figure 7

Figure 7: Neuroprotective Properties of a Standardized Extract from <i>Myracrodruon urundeuva</i> Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson’s Disease Model in Rats 

Figure 7 | Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson’s Disease Model in Rats 